Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 31;366(22):2051-3.
doi: 10.1056/NEJMp1202623. Epub 2012 May 9.

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

Dennis M Black  1 , Douglas C Bauer, Ann V Schwartz, Steven R Cummings, Clifford J Rosen
Affiliations

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

Dennis M Black et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Food and Drug Administration. Background document for meeting of Advisory Committee for Reproductive Health Drugs and Drug Safety and Risk Management Advisory Committee. 2011 Sep 9; http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMateria....
    1. Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-Term Extension (FLEX): a randomized trial. JAMA. 2006;296:2927–38. - PubMed
    1. Black DM, Reid IR, Boonen S, et al. The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) J Bone Miner Res. 2012;27:243–54. - PMC - PubMed
    1. Schwartz AV, Bauer DC, Cummings SR, et al. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res. 2010;25:976–82. - PubMed

MeSH terms

Substances